For Immediate Release: October 20, 2021 Today, the U.S. Food and Drug Administration took action to expand the use of a booster dose for COVID-19 vaccines in eligible populations. The agency is amending the emergency use authorizations (EUA) for COVID-19 vaccines to...
Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for a booster shot of COVID-19 vaccines in certain populations. The Food and Drug Administration’s (FDA) authorizationexternal...
“The Alpha-1 Foundation strongly agrees with the American Thoracic Society (ATS) position objecting to the FDA’s authorization of the tobacco-flavored versions of RJ Reynolds e-cigarette brand Vuse. While the FDA rejected sweet-flavored versions of the...
“The update shared this week by Inhibrx on their Recombinant Alpha-1-antitrypsin (INBRX-101) is exciting news for the Alpha-1 Community. The potential for a once a month dosing of Alpha-1-antitrypsin could be a very important advance in therapies for...
Today, the Alpha-1 Foundation received the following communication from CSL Behring, regarding Zemaira®, their prescription drug for augmentation therapy for the treatment of Alpha-1 Antitrypsin Deficiency (Alpha-1). “The Alpha-1 Foundation is committed to provide...
FOR IMMEDIATE RELEASE The Alpha-1 Foundation announces the selection of Mr. Scott Santarella as the new President and Chief Executive Officer (CEO). Scott joins us with extensive experience in building and transforming disease-focused non-profits and a strong passion...
